Search results
The hell of drug pricing boards
Maryland Matters via Yahoo News· 11 hours agoJames K. Glassman, the well-known economist whose clients have included pharmaceutical companies, makes the case against prescription drug affordability boards. The post The hell of drug pricing boards appeared first on Maryland Matters.
3 Reasons to Buy AbbVie Stock on the Dip
Motley Fool via Yahoo Finance· 4 days agoJeff Stewart, executive vice president of the company, pointed out that Skyrizi has a market share in the U.S. of 35% in psoriasis, more than twice that...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 5 hours ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 6 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
The Huffington Post· 2 days agoThe reality TV star wore a custom Maison Margiela Artisanal gown by John Galliano with a metal...
Many Patients With Advanced MCC Not Receiving Immunotherapy
Medscape· 4 days agoDespite improved survival rates and guideline recommendations, many eligible patients with...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 2 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 6 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic...
2 Magnificent Dividend Stocks to Hold for the Next Decade
Motley Fool via Yahoo Finance· 4 days agoHowever, one of Novartis' most important products, psoriasis treatment Cosentyx, will run out of...
New era for pot regulation leaves old problem: Many cannabis companies can’t find a bank
The Journal Times· 5 days agoThe Biden administration's move to reclassify marijuana as a less dangerous but still controlled...
